Rubrik: Fachthemen
(Treffer aus pharmind, Nr. 04, Seite 482 (2018))
Minas W
Transforming a R&D-oriented start-up into a GMP-compliant biopharmaceutical production organization / Minas • Transforming a R&D-oriented start-up · Minas W · Chemgineering Technology AG, Münchenstein, Switzerland
Universities are proud of any start-up that is based on research and development merits that they have obtained as this is an indication of innovation and successful research. As a result, the number of spin-offs from academia has risen over the past few decades. This is a rather recent development because until not so long ago the academia in life sciences, particularly in central Europe, was rather skeptical about commercialization of their research or even receiving funding from third parties, as this might impair their scientific independence and compromise their academic freedom. However, in the advent of genetic engineering this ...